Table 4. Validation analysis of u-FCMSS in the second cohort including MDS and non-clonal cytopenias diseases.
Conventional diagnosis (clinical and morphologic diagnosis) | ||||
MDS | Non-clonal cytopenias | Total | ||
u-FCMSS diagnosis | MDS | 78 (a) | 3 (b) | 81 (a+b) |
Non-MDS | 12 (c) | 42 (d) | 54 (c+d) | |
total | 90 (a+c) | 45 (b+d) |
Sensitivity = [a/(a+c)]×100% = 86.7%.
Specificity = [d/(b+d)]×100% = 93.3%.
Positive predictive value = [a/(a+b)]×100% = 96.3%.
Negative predictive value = [d/(c+d)]×100% = 77.8%.
Diagnosis agreement rate = [(a+d)/(a+b+c+d)]×100% = 88.9%.